Zobrazeno 1 - 10
of 158
pro vyhledávání: '"Franck Housseau"'
Autor:
Alex Lee, Drew Pardoll, Franck Housseau, Cynthia Sears, Fyza Shaikh, Kellie N Smith, Boyang Zhang, Pakhi Birla, Lansaol Yang
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/c2cab0131254414099302aeb1199125b
Autor:
Annemarie Boleij, Payam Fathi, William Dalton, Ben Park, Xinqun Wu, David Huso, Jawara Allen, Sepideh Besharati, Robert A. Anders, Franck Housseau, Amanda E. Mackenzie, Laura Jenkins, Graeme. Milligan, Shaoguang Wu, Cynthia L. Sears
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-14 (2021)
Boleij et al. show that G protein-coupled receptor 35 (GPR35) regulates the responses to enterotoxigenic Bacteroides fragilis (ETBF) in colonic epithelial cells. They find that GPR35-deficiency nearly protected mice from ETBF-induced death, suggestin
Externí odkaz:
https://doaj.org/article/2986eba9551643dc8608d3a4c5b5b496
Autor:
Jessica Queen, Jada C. Domingue, James Robert White, Courtney Stevens, Barath Udayasuryan, Tam T. D. Nguyen, Shaoguang Wu, Hua Ding, Hongni Fan, Madison McMann, Alina Corona, Tatianna C. Larman, Scott S. Verbridge, Franck Housseau, Daniel J. Slade, Julia L. Drewes, Cynthia L. Sears
Publikováno v:
mBio, Vol 13, Iss 1 (2022)
ABSTRACT Fusobacteria are commonly associated with human colorectal cancer (CRC), but investigations are hampered by the absence of a stably colonized murine model. Further, Fusobacterium nucleatum subspecies isolated from human CRC have not been inv
Externí odkaz:
https://doaj.org/article/0a9d26e8a85f4e6d870c28b44bda70be
Autor:
James White, Patrick Forde, Juan Fu, Drew Pardoll, Franck Housseau, Cynthia Sears, Richard Blosser, Sudipto Ganguly, Fyza Shaikh, Joell Gills, Fuad Mohammad, Courtney Stevens, Hua Ding, Tatianna Larman
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/ee9bff57d8bc45e5b2ebce5c484ea700
Autor:
Peng Huang, Peter B. Illei, Wilbur Franklin, Pei-Hsun Wu, Patrick M. Forde, Saeed Ashrafinia, Chen Hu, Hamza Khan, Harshna V. Vadvala, Ie-Ming Shih, Richard J. Battafarano, Michael A. Jacobs, Xiangrong Kong, Justine Lewis, Rongkai Yan, Yun Chen, Franck Housseau, Arman Rahmim, Elliot K. Fishman, David S. Ettinger, Kenneth J. Pienta, Denis Wirtz, Malcolm V. Brock, Stephen Lam, Edward Gabrielson
Publikováno v:
Cancers, Vol 14, Iss 17, p 4150 (2022)
Background: Prognostic risk factors for completely resected stage IA non-small-cell lung cancers (NSCLCs) have advanced minimally over recent decades. Although several biomarkers have been found to be associated with cancer recurrence, their added va
Externí odkaz:
https://doaj.org/article/5a8ed258d00c4298b73a5d518e9c3a1c
Autor:
Drew M Pardoll, Gady Cojocaru, Nicholas Siegel, Franck Housseau, Robert Anders, Richard Blosser, Elizabeth D Thompson, Woonyoung Choi, Adam Levin, David McConkey, Nicolas Llosa, Carol D Morris, John A Ligon, Emily Han-Chung Hsiue, Teniola F Oke, Megan H Fong, Brian Ladle, Christine A Pratilas, Daniel S Rhee, Christian F Meyer, Ada J Tam, Aditya Suru
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)
Background Current therapy for osteosarcoma pulmonary metastases (PMs) is ineffective. The mechanisms that prevent successful immunotherapy in osteosarcoma are incompletely understood. We investigated the tumor microenvironment of metastatic osteosar
Externí odkaz:
https://doaj.org/article/92d577b324804764ba66065cfc75af6b
Autor:
Kellie N. Smith, Nicolas J. Llosa, Tricia R. Cottrell, Nicholas Siegel, Hongni Fan, Prerna Suri, Hok Yee Chan, Haidan Guo, Teniola Oke, Anas H. Awan, Franco Verde, Ludmila Danilova, Valsamo Anagnostou, Ada J. Tam, Brandon S. Luber, Bjarne R. Bartlett, Laveet K. Aulakh, John-William Sidhom, Qingfeng Zhu, Cynthia L. Sears, Leslie Cope, William H. Sharfman, Elizabeth D. Thompson, Joanne Riemer, Kristen A. Marrone, Jarushka Naidoo, Victor E. Velculescu, Patrick M. Forde, Bert Vogelstein, Kenneth W. Kinzler, Nickolas Papadopoulos, Jennifer N. Durham, Hao Wang, Dung T. Le, Sune Justesen, Janis M. Taube, Luis A. Diaz, Julie R. Brahmer, Drew M. Pardoll, Robert A. Anders, Franck Housseau
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-8 (2019)
Abstract Background Several predictive biomarkers are currently approved or are under investigation for the selection of patients for checkpoint blockade. Tumor PD-L1 expression is used for stratification of non-small cell lung (NSCLC) patients, with
Externí odkaz:
https://doaj.org/article/1bbf8602f6f8428183fdc7d49f984cca
Autor:
Kellie N. Smith, Nicolas J. Llosa, Tricia R. Cottrell, Nicholas Siegel, Hongni Fan, Prerna Suri, Hok Yee Chan, Haidan Guo, Teniola Oke, Anas H. Awan, Franco Verde, Ludmila Danilova, Valsamo Anagnostou, Ada J. Tam, Brandon S. Luber, Bjarne R. Bartlett, Laveet K. Aulakh, John-William Sidhom, Qingfeng Zhu, Cynthia L. Sears, Leslie Cope, William H. Sharfman, Elizabeth D. Thompson, Joanne Riemer, Kristen A. Marrone, Jarushka Naidoo, Victor E. Velculescu, Patrick M. Forde, Bert Vogelstein, Kenneth W. Kinzler, Nickolas Papadopoulos, Jennifer N. Durham, Hao Wang, Dung T. Le, Sune Justesen, Janis M. Taube, Luis A. Diaz Jr, Julie R. Brahmer, Drew M. Pardoll, Robert A. Anders, Franck Housseau
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-2 (2019)
Externí odkaz:
https://doaj.org/article/53de6d1b2ed144d48e2c742123df82a4
Autor:
Christopher Cherry, James I. Andorko, Kavita Krishnan, Joscelyn C. Mejías, Helen Hieu Nguyen, Katlin B. Stivers, Elise F. Gray-Gaillard, Anna Ruta, Jin Han, Naomi Hamada, Masakazu Hamada, Ines Sturmlechner, Shawn Trewartha, John H. Michel, Locke Davenport Huyer, Matthew T. Wolf, Ada J. Tam, Alexis N. Peña, Shilpa Keerthivasan, Claude Jordan Le Saux, Elana J. Fertig, Darren J. Baker, Franck Housseau, Jan M. van Deursen, Drew M. Pardoll, Jennifer H. Elisseeff
Publikováno v:
GeroScience.
Data from Immunopathologic Stratification of Colorectal Cancer for Checkpoint Blockade Immunotherapy
Autor:
Robert A. Anders, Franck Housseau, Hao Wang, Drew M. Pardoll, Luis A. Diaz, Dung T. Le, Cynthia L. Sears, Jennifer N. Durham, Elizabeth M. Jaffee, Elizabeth D. Thompson, Laveet K. Aulakh, Bjarne R. Bartlett, Qingfeng Zhu, Teniola Oke, Anas H. Awan, Nicholas Siegel, Brandon Luber, Nicolas J. Llosa
Mismatch-repair deficiency in solid tumors predicts their response to PD-1 blockade. Based on this principle, pembrolizumab is approved as standard of care for patients with unresectable or metastatic microsatellite instability–high (MSI-H) cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26bd97c0a7493fb2d388f0fc44d9d416
https://doi.org/10.1158/2326-6066.c.6549880
https://doi.org/10.1158/2326-6066.c.6549880